Literature DB >> 21290211

Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.

Ja-Lok Ku1, Kyung-Hee Kim, Jin-Sung Choi, You-Kyung Jeon, Sung-Hee Kim, Young-Kyoung Shin, Tae-You Kim, Yung-Jue Bang, Woo Ho Kim, Jae-Gahb Park.   

Abstract

BACKGROUND: Six human lung cancer cell lines (SNU-371, SNU-963, SNU-1327, SNU-1330, SNU-2292 and SNU-2315) were newly established through primary cell cultures. These cell lines were derived from a pulmonary blastoma, a small cell lung cancer, three adenocarcinomas and a squamous cell carcinoma of the lung of six Korean lung cancer patients.
METHODS: The histopathology of the primary tumors and their in vitro growth characteristics were described. DNA fingerprinting analysis and genetic alterations in the p53, β-catenin, TGFβRII, K-ras and EGFR genes were conducted. mRNA expressions levels of E-cadherin, COX-2, MDR1, MXR, CGA, synatophysin and TTF1 genes were investigated and sensitivity to anticancer drugs was screened.
RESULTS: Five cell lines grew as adherent cells and one cell line grew as floating aggregates. All lines were free of mycoplasma or bacteria and were proven unique by DNA fingerprinting analysis. A significant polymorphism at codon 72 (Arg to Pro) of the p53 gene was found in one line (SNU-1327) and a mutation at codon 176 was found in SNU-2292. No mutations in the K-ras, β-catenin and TGF-βRII genes were observed. E-cadherin was not expressed in SNU-371 and COX-2 was overexpressed in SNU-1330, SNU-2292 and SNU-2315 cell lines. MDR1 was overexpressed in SNU-371 and SNU-2292 cell lines and MXR was overexpressed in SNU-1327 cell line. Interestingly, the SNU-371 cell line derived from a pulmonary blastoma and which overexpressed MDR1 displayed cross resistance for several anticancer drugs. Neuroendocrine markers, chromogranin A and synaptophysin, were overexpressed in the small cell lung cancer cell line, SNU-963 and thyroid transcription factor-1 was also over expressed in this cell line. Two mutations (p.Glu746_Ser752delinsVal and p.Glu746_Ala750del) in exon 19 of EGFR were found in SNU-1330 and SNU-2315 cell lines, respectively.
CONCLUSION: These well-characterized lung cancer cell lines may be useful tools for investigations of the biological characteristics of lung cancers, particularly for investigations related to mutations of EGFR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21290211     DOI: 10.1007/s13402-010-0004-6

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  35 in total

1.  Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.

Authors:  A F Gazdar; H K Oie
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

2.  Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.

Authors:  T Hashimoto; Y Tokuchi; M Hayashi; Y Kobayashi; K Nishida; S Hayashi; Y Ishikawa; K Nakagawa; J Hayashi; E Tsuchiya
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations.

Authors:  K Iwao; S Nakamori; M Kameyama; S Imaoka; M Kinoshita; T Fukui; S Ishiguro; Y Nakamura; Y Miyoshi
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

4.  The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.

Authors:  Masaki Tokumo; Shinichi Toyooka; Katsuyuki Kiura; Hisayuki Shigematsu; Kunitoshi Tomii; Motoi Aoe; Kouichi Ichimura; Toshihide Tsuda; Masaaki Yano; Kazunori Tsukuda; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto; Hiroshi Date; Adi F Gazdar; Nobuyoshi Shimizu
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

5.  Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers.

Authors:  S L Lu; W C Zhang; Y Akiyama; T Nomizu; Y Yuasa
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

6.  Cell culture methods for human lung cancer.

Authors:  A F Gazdar; H K Oie
Journal:  Cancer Genet Cytogenet       Date:  1986-01-01

7.  Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.

Authors:  Rajeev Rajendra; Murugesan K Gounder; Ahamed Saleem; Jan H M Schellens; Douglas D Ross; Susan E Bates; Patrick Sinko; Eric H Rubin
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

8.  Chromogranin A gene expression in non-small cell lung carcinomas.

Authors:  G Abbona; M Papotti; L Viberti; L Macrĭ; A Stella; G Bussolati
Journal:  J Pathol       Date:  1998-10       Impact factor: 7.996

9.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

Authors:  Patrick Dumont; J I-Ju Leu; Anthony C Della Pietra; Donna L George; Maureen Murphy
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

10.  Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.

Authors:  S Hougaard; P Nørgaard; N Abrahamsen; H L Moses; M Spang-Thomsen; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  5 in total

1.  Establishment and characterization of a lung cancer cell line, SMC-L001, from a lung adenocarcinoma.

Authors:  So-Jung Choi; Hyeseon Lee; Chungyoul Choe; Yong-Sung Shin; Jinseon Lee; Sung-Hwan Moon; Jhingook Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-02-26       Impact factor: 2.416

2.  EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.

Authors:  Dalia Ercan; Hwan Geun Choi; Cai-Hong Yun; Marzia Capelletti; Ting Xie; Michael J Eck; Nathanael S Gray; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2015-05-06       Impact factor: 12.531

3.  Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.

Authors:  J-K Lee; S Louzada; Y An; S Y Kim; S Kim; J Youk; S Park; S H Koo; B Keam; Y K Jeon; J-L Ku; F Yang; T M Kim; Y S Ju
Journal:  Ann Oncol       Date:  2017-04-01       Impact factor: 32.976

4.  The ethanol extract of Garcinia subelliptica Merr. induces autophagy.

Authors:  Kyun Ha Kim; Ji Yeon Lee; Wan Yi Li; Sangwoo Lee; Han-Sol Jeong; Jun-Yong Choi; Myungsoo Joo
Journal:  BMC Complement Med Ther       Date:  2021-11-10

Review 5.  Mitosis-targeted anti-cancer therapies: where they stand.

Authors:  K-S Chan; C-G Koh; H-Y Li
Journal:  Cell Death Dis       Date:  2012-10-18       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.